Long-term donepezil use for dementia with Lewy bodies: results from an open-label extension of Phase III trial

INTRODUCTION: The long-term efficacy and safety of donepezil 10 mg in patients with dementia with Lewy bodies (DLB) were investigated in a 52-week Phase 3 trial. METHODS: This 52-week study consisted of 16-week randomized placebo-controlled (RCT) and 36-week open-label extension phases. Of 142 DLB p...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Etsuro, Ikeda, Manabu, Nagai, Reiko, Matsuo, Kazutaka, Nakagawa, Masaki, Kosaka, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338564/
https://www.ncbi.nlm.nih.gov/pubmed/25713600
http://dx.doi.org/10.1186/s13195-014-0081-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338564/
https://www.ncbi.nlm.nih.gov/pubmed/25713600
http://dx.doi.org/10.1186/s13195-014-0081-2

Ejemplares similares